Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet substitutes.

M A Blajchman1

  • 1Department of Pathology, McMaster University, Hamilton, Ontario, Canada.

Vox Sanguinis
|August 12, 2000
PubMed
Summary

Researchers are developing novel hemostatic platelet products and substitutes for long-term storage. These innovative blood components aim to improve bleeding disorder treatments and patient safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2009
Same author

Human FVII(K62E) does not exhibit enhanced binding to tissue factor.

Journal of thrombosis and haemostasis : JTH·2008
Same author

The clinical benefits of the leukoreduction of blood products.

The Journal of trauma·2006
Same author

Transfusion immunomodulation or TRIM: what does it mean clinically?

Hematology (Amsterdam, Netherlands)·2005
Same author

Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.

Transfusion·2005
Same author

In vitro evaluation of prestorage pooled leukoreduced whole blood-derived platelets stored for up to 7 days.

Transfusion·2005

Area of Science:

  • Biotechnology
  • Hematology
  • Materials Science

Background:

  • Platelet transfusions are critical for managing bleeding disorders but face storage limitations.
  • Current methods for platelet preservation are insufficient for long-term clinical needs.
  • Development of hemostatically active platelet substitutes is a significant scientific challenge.

Purpose of the Study:

  • To review experimental approaches for producing long-term storable hemostatic human platelet products and substitutes.
  • To explore both platelet-derived and non-platelet-derived hemostatic agents.
  • To highlight the ongoing advancements in platelet substitute technology for clinical application.

Main Methods:

  • Review of experimental strategies including cryopreservation, cold storage, and photochemical treatments.
  • Exploration of platelet membrane and lyophilized platelet technologies.
  • Investigation of non-platelet substitutes like modified red blood cells, liposomes, and microcapsules.

Main Results:

  • Multiple methods are being explored for producing stable, hemostatically active platelet products.
  • Non-platelet-derived substitutes incorporating hemostatic agents show promise.
  • Ongoing research indicates increasing efficacy and safety of platelet substitutes.

Conclusions:

  • Significant progress is being made in developing advanced hemostatic platelet products and substitutes.
  • These innovations promise safer and more effective treatments for patients with bleeding risks.
  • The future of hemostasis management includes advanced, storable platelet substitutes.

Related Experiment Videos